SUBSCRIBE
SUBSCRIBE
News   Policy

GlaxoSmithKline (JOBS) Temporarily Withdraws Avodart Cancer Filing

November 23, 2009 | 
1 min read
Bookmark and Share

Reuters -- GlaxoSmithKline temporarily withdrew its application to U.S. regulators for a new use of its Avodart drug in preventing prostate cancer because of a technical problem with the file, it said on Monday.
Regulatory
GSK
MORE ON THIS TOPIC
Finding Talent. Big Hands with Magnifying Glass Recruiting People. vector
Regulatory
FDA probes abortion pill anew after court keeps mail access alive
April 10, 2026
 · 
2 min read
 · 
Tristan Manalac
Business people and concepts vector art exit
Government
PhMRA’s long-standing leader Steve Ubl to leave lobby group by year-end
April 9, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma
April 8, 2026
 · 
1 min read
 · 
Heather McKenzie
Many various colored tablets and pills are stacked in shopping cart, percent signs are around. Concept of buying of medicines, online sales of medication, discounts and promotions in pharmacy
Drug pricing
AbbVie Puts Humira on TrumpRx at Steep Discount as Tariff Threat Solidifies
April 7, 2026
 · 
1 min read
 · 
Tristan Manalac